Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€13.90

€13.90

11.200%
1.4
11.200%
€20.55
 
22.07.24 / Tradegate WKN: A2PLTL / Symbol: STOK / Name: Stoke Therapeutics / Stock / Biotechnology & Medical Research / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Stoke Therapeutics Inc Stock

A very strong showing by Stoke Therapeutics Inc today, with an increase of €1.40 (11.200%) compared to yesterday's price.
We see a rather positive sentiment for Stoke Therapeutics Inc with 17 Buy predictions and 1 Sell predictions.
As a result the target price of 20 € shows a positive potential of 43.88% compared to the current price of 13.9 € for Stoke Therapeutics Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Stoke Therapeutics Inc stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Stoke Therapeutics Inc in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
B****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Stoke Therapeutics Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Stoke Therapeutics Inc 11.200% 7.752% 4.511% - - - -
Personalis Inc -11.290% 43.862% 126.383% 31.814% 27.885% -85.441% -
Immuron -4.550% 0.917% 21.547% 34.969% 31.737% -42.408% -

Comments

Prediction Buy
Perf. (%) 6.92%
Target price 15.623
Change
Ends at 11.07.25

Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 6.92%
Target price 20.546
Change
Ends at 28.06.25

Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 24.55%
Target price 32.470
Change
Ends at 07.05.25

Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
Show more